By Dr Natalie Haworth
I write today with profound disappointment and deep concern following the government’s recent announcement on aesthetic regulation. Once again, we see rhetoric over action, a declaration of reform without substance.
Describing botulinum toxin (Botox) and dermal fillers as “low-risk” is not only misleading but deeply irresponsible. In recent months, dozens of patients across County Durham and Darlington suffered life-threatening iatrogenic botulism, manifesting with drooping eyelids, double vision, difficulty swallowing, slurred speech, and respiratory distress, many requiring intensive care and anti-toxin treatment (cddft.nhs.uk). In one harrowing incident, five patients presented simultaneously at the same A&E department, exhausting the hospital’s supply of anti-toxin (rehis.com).
How can the government possibly characterize these treatments as “low risk” when they have propelled patients into ICU and required emergency neurological intervention?
This announcement, tied to Home Office powers instituted under the Health and Care Act 2022, proposes delegating oversight to local authorities via a licensing scheme. This approach demonstrates a fundamental misunderstanding and is frankly reckless. Public health is not a matter for local council discretion. These bodies are not equipped to assess clinical competency, understand pharmacological dosing, or safe storage of prescription-only medications. Their involvement threatens to dilute responsibility, not enhance patient safety.
Moreover, this approach creates a glaring disparity. Medical professionals will shoulder heavier regulation, while non-medical injectors remain largely unregulated, allowed to continue practicing in grey zones without accountability or training. This is not reform, it is a regulatory illusion that protects complacency while perpetuating patient risk.
I had hoped change would come with a new government, especially with the involvement of the Women and Equalities Commission. Aesthetic safety is not simply a public health issue, it is a women’s issue. The perception that aesthetic medicine is cosmetic, frivolous, or a lifestyle choice, a matter of vanity, reflects a deep-rooted misogyny. It continues to strip legitimacy from the concerns of women who have been harmed by unregulated practice, and from the professionals advocating for serious reform.
The Durham botulism outbreak is not an isolated warning, it is a public health crisis borne of inadequate regulation, counterfeit products, and unchecked practice. Allowing superficial policies that claim progress while failing to implement meaningful, enforceable standards is nothing short of negligence.
I have campaigned, submitted evidence, and taken these issues to decision-makers not for personal recognition but to protect patients, particularly women, from preventable harm. This response further underscores how little the government values these concerns.
To those in power who claim to protect women and public health: intentions mean nothing without impact. If you truly believe in patient safety, you must:
- Restrict high-risk injectables such as Botox and fillers to qualified healthcare professionals only
- Establish a single, central regulator with clinical oversight, not devolved to councils
- Ban non-medical individuals from independently administering prescription-only treatments
- Ensure enforcement is backed by legal and criminal consequences for rogue operators
Until such measures are enacted, I, and patients, will continue to speak out. Because every life lost, every patient harmed, every tragedy like Alice Webb’s, is further evidence that we cannot afford half measures.
This is not a women’s issue quietly tucked away, it is a frontline problem that demands urgent, meaningful resolution, not cheap optics.
The time for token gestures is over. We demand real regulation. Now.